Taro Pharmaceutical Industries - stock earnings
TARO Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 28, 2024 BeforeMarket | - / 0.3100000000 | - | - / 156.1 million | - |
TARO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 20.2 million USD | 157.1 million USD |
| 2023Q3 | 8.5 million USD | 148.2 million USD |
| 2023Q2 | 10.0 million USD | 158.9 million USD |
| 2023Q1 | 6.9 million USD | 146.6 million USD |
| 2022Q4 | 7.3 million USD | 139.2 million USD |
| 2022Q3 | -2.8 million USD | 130.5 million USD |
| 2022Q2 | 27.4 million USD | 143.3 million USD |
| 2022Q1 | 27.4 million USD | 143.3 million USD |
| 2021Q4 | 26.3 million USD | 139.0 million USD |
| 2021Q3 | 23.3 million USD | 132.0 million USD |
| 2021Q2 | -18.8 million USD | 147.1 million USD |
| 2021Q1 | -29.8 million USD | 148.3 million USD |
| 2020Q4 | 32.9 million USD | 140.1 million USD |
| 2020Q3 | 45.1 million USD | 142.8 million USD |
| 2020Q2 | -434.9 million USD | 117.6 million USD |
| 2020Q1 | 54.2 million USD | 174.9 million USD |
| 2019Q4 | 67.7 million USD | 147.7 million USD |
| 2019Q3 | 56.2 million USD | 160.9 million USD |
| 2019Q2 | 66.2 million USD | 161.3 million USD |
| 2019Q1 | 58.4 million USD | 179.9 million USD |
| 2018Q4 | 93.5 million USD | 176.4 million USD |
| 2018Q3 | 62.6 million USD | 159.0 million USD |
| 2018Q2 | 67.3 million USD | 154.6 million USD |
| 2018Q1 | 86.3 million USD | 175.2 million USD |
| 2017Q4 | 18.0 million USD | 155.5 million USD |
| 2017Q3 | 52.4 million USD | 169.9 million USD |
| 2017Q2 | 54.5 million USD | 161.3 million USD |
| 2017Q1 | 83.0 million USD | 196.4 million USD |
| 2016Q4 | 139.8 million USD | 220.4 million USD |
| 2016Q3 | 123.7 million USD | 228.8 million USD |
| 2016Q2 | 109.9 million USD | 233.8 million USD |
| 2016Q1 | 115.0 million USD | 265.1 million USD |
| 2015Q4 | 189.0 million USD | 258.3 million USD |
| 2015Q3 | 133.3 million USD | 212.1 million USD |
| 2015Q2 | 152.3 million USD | 244.2 million USD |
| 2015Q1 | 152.3 million USD | 244.2 million USD |
| 2014Q4 | 142.5 million USD | 237.7 million USD |
| 2014Q3 | 143.4 million USD | 250.8 million USD |
| 2014Q2 | 89.6 million USD | 187.2 million USD |
| 2014Q1 | 89.6 million USD | 187.2 million USD |
| 2013Q4 | 115.6 million USD | 213.6 million USD |
| 2013Q3 | 96.3 million USD | 205.3 million USD |
| 2013Q2 | 49.2 million USD | 165.1 million USD |
| 2013Q1 | 49.2 million USD | 165.1 million USD |
| 2012Q4 | 88.8 million USD | 185.7 million USD |
| 2012Q3 | 65.4 million USD | 161.0 million USD |
| 2012Q2 | 62.9 million USD | 159.2 million USD |
| 2012Q1 | 47.3 million USD | 145.1 million USD |
| 2011Q4 | 62.4 million USD | 148.1 million USD |
| 2011Q3 | 58.9 million USD | 138.3 million USD |
| 2011Q2 | 35.7 million USD | 111.6 million USD |
| 2011Q1 | 25.7 million USD | 107.7 million USD |
| 2010Q4 | 16.0 million USD | 102.0 million USD |
| 2010Q3 | 18.9 million USD | 103.2 million USD |
| 2010Q2 | 18.9 million USD | 98.0 million USD |
| 2010Q1 | -84.4 million USD | 28.7 million USD |
| 2009Q4 | 80.7 million USD | 82.1 million USD |
| 2009Q3 | 9.7 million USD | 93.9 million USD |
| 2009Q2 | 12.5 million USD | 96.8 million USD |
| 2009Q1 | 11.1 million USD | 84.9 million USD |
| 2008Q4 | -2.6 million USD | 72.4 million USD |
| 2008Q3 | 12.5 million USD | 90.4 million USD |
| 2008Q2 | 13.0 million USD | 88.1 million USD |
| 2008Q1 | 7.5 million USD | 78.1 million USD |
| 2007Q4 | 20.1 million USD | 87.8 million USD |
| 2006Q4 | ? USD | 252.3 million USD |
| 2005Q4 | -6.9 million USD | 72.4 million USD |
| 2005Q3 | 2.1 million USD | 72.5 million USD |
| 2005Q2 | 6.5 million USD | 78.6 million USD |
| 2005Q1 | 5.0 million USD | 78.5 million USD |
| 2004Q4 | 4.8 million USD | 77.7 million USD |
| 2004Q3 | 4.0 million USD | 73.3 million USD |
| 2004Q2 | -8.9 million USD | 49.1 million USD |
| 2004Q1 | 11.1 million USD | 84.1 million USD |
| 2003Q4 | 16.6 million USD | 88.6 million USD |
| 2003Q3 | 15.7 million USD | 83.1 million USD |
| 2003Q2 | 14.8 million USD | 74.8 million USD |
| 2003Q1 | 14.0 million USD | 69.0 million USD |
| 2002Q4 | 12.9 million USD | 62.0 million USD |
| 2002Q3 | 11.6 million USD | 55.5 million USD |
| 2002Q2 | 10.2 million USD | 49.6 million USD |
| 2002Q1 | 9.9 million USD | 44.5 million USD |
| 2001Q4 | 9.8 million USD | 44.0 million USD |
| 2001Q3 | 7.3 million USD | 41.4 million USD |
| 2001Q2 | 6.1 million USD | 36.4 million USD |
| 2001Q1 | 3.2 million USD | 28.4 million USD |
| 2000Q4 | 3.5 million USD | 30.0 million USD |
| 2000Q3 | 2.8 million USD | 27.2 million USD |
| 2000Q2 | 2.1 million USD | 24.4 million USD |
| 2000Q1 | 1.6 million USD | 22.2 million USD |
| 1999Q4 | 1.7 million USD | 22.3 million USD |
| 1999Q3 | 1.7 million USD | 22.1 million USD |
| 1999Q2 | 1.3 million USD | 21.0 million USD |
| 1999Q1 | 800000 USD | 18.4 million USD |
| 1998Q4 | 1.2 million USD | 19.7 million USD |
| 1998Q3 | 700000 USD | 17.2 million USD |
| 1998Q2 | 300000 USD | 16.3 million USD |
| 1998Q1 | 100000 USD | 13.5 million USD |
| 1997Q4 | 200000 USD | 16.1 million USD |
| 1997Q3 | 800000 USD | 16.7 million USD |
| 1997Q2 | 400000 USD | 15.6 million USD |
| 1997Q1 | 100000 USD | 12.7 million USD |
| 1996Q4 | 700000 USD | 15.0 million USD |
| 1996Q3 | 700000 USD | 14.7 million USD |
| 1996Q2 | 600000 USD | 14.1 million USD |
| 1996Q1 | 200000 USD | 12.7 million USD |
| 1995Q4 | 100000 USD | 12.5 million USD |
| 1995Q3 | ? USD | 12.8 million USD |
| 1995Q2 | 1.2 million USD | 13.1 million USD |
| 1995Q1 | 700000 USD | 11.2 million USD |
| 1994Q4 | 1.1 million USD | 13.1 million USD |
| 1994Q3 | 700000 USD | 9.9 million USD |
| 1994Q2 | 1.0 million USD | 10.0 million USD |
| 1994Q1 | 500000 USD | 9.1 million USD |
| 1993Q4 | 500000 USD | 7.9 million USD |
| 1993Q3 | -100000 USD | 6.4 million USD |
| 1993Q2 | ? USD | 7.6 million USD |
| 1993Q1 | -200000 USD | 6.6 million USD |
| 1992Q4 | -600000 USD | 7.2 million USD |
| 1992Q3 | 600000 USD | 7.2 million USD |
| 1992Q2 | 400000 USD | 6.4 million USD |
| 1992Q1 | 500000 USD | 5.7 million USD |
| 1991Q4 | ? USD | 5.7 million USD |
| 1991Q3 | 600000 USD | 5.9 million USD |
| 1991Q2 | -200000 USD | 4.7 million USD |
| 1991Q1 | 500000 USD | 4.5 million USD |
| 1990Q4 | ? USD | 3.8 million USD |
| 1990Q3 | ? USD | 3.3 million USD |
| 1990Q2 | ? USD | 3.3 million USD |
| 1990Q1 | -200000 USD | 2.8 million USD |
| 1989Q4 | ? USD | 3.2 million USD |
| 1989Q3 | ? USD | 3.4 million USD |
| 1989Q2 | ? USD | 2.7 million USD |
| 1989Q1 | ? USD | 2.6 million USD |
| 1988Q4 | ? USD | 1.8 million USD |
| 1988Q3 | ? USD | 2.1 million USD |
| 1988Q2 | ? USD | 2.6 million USD |
| 1988Q1 | ? USD | 2.4 million USD |
| 1987Q4 | ? USD | 2.8 million USD |
| 1987Q3 | ? USD | 2.0 million USD |
| 1987Q2 | ? USD | 2.0 million USD |
| 1987Q1 | ? USD | 2.0 million USD |
TARO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 25.4 million USD | 573.0 million USD |
| 2022 | 58.3 million USD | 561.3 million USD |
| 2021 | -400.7 million USD | 549.0 million USD |
| 2020 | 244.2 million USD | 644.8 million USD |
| 2019 | 281.8 million USD | 669.9 million USD |
| 2018 | 211.2 million USD | 661.9 million USD |
| 2017 | 456.4 million USD | 879.4 million USD |
| 2016 | 540.9 million USD | 950.8 million USD |
| 2015 | 484.3 million USD | 862.9 million USD |
| 2014 | 360.4 million USD | 759.3 million USD |
| 2013 | 266.2 million USD | 671.0 million USD |
| 2012 | 204.3 million USD | 543.1 million USD |
| 2011 | 34.3 million USD | 319.6 million USD |
| 2010 | -82.7 million USD | 252.3 million USD |
| 2009 | 30.5 million USD | 327.4 million USD |
| 2008 | 34.3 million USD | 318.5 million USD |
| 2007 | 5.7 million USD | 297.7 million USD |
| 2006 | 100000 USD | 288.6 million USD |
| 2005 | 11.1 million USD | 284.1 million USD |
| 2004 | 61.2 million USD | 315.5 million USD |
| 2003 | 44.6 million USD | 211.6 million USD |
| 2002 | 26.0 million USD | 150.1 million USD |
| 2001 | 10.0 million USD | 103.8 million USD |
| 2000 | 5.5 million USD | 83.8 million USD |
| 1999 | 2.3 million USD | 66.7 million USD |
| 1998 | 1.4 million USD | 61.0 million USD |
| 1997 | 2.2 million USD | 56.5 million USD |
| 1996 | 2.0 million USD | 49.6 million USD |
| 1995 | 3.4 million USD | 42.1 million USD |
| 1994 | 200000 USD | 28.5 million USD |
| 1993 | 900000 USD | 26.5 million USD |
| 1992 | 800000 USD | 20.6 million USD |
| 1991 | -200000 USD | 13.3 million USD |
| 1990 | -200000 USD | 11.8 million USD |
| 1989 | 100000 USD | 9.2 million USD |
| 1988 | ? USD | 8.8 million USD |
TARO
Price: $42.45
52 week price:
Earnings Per Share: 1.22 USD
P/E Ratio: 34.98
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 10328
Ebitda: 458.4 millionMarket Capitalization: 1.6 billion